Absci ABSI Stock
Absci Price Chart
Absci ABSI Financial and Trading Overview
| Absci stock price | 9.76 USD |
| Previous Close | 10.6 USD |
| Open | 10.34 USD |
| Bid | 7.59 USD x 200 |
| Ask | 12.99 USD x 200 |
| Day's Range | 10.1 - 10.61 USD |
| 52 Week Range | 2.24 - 12.06 USD |
| Volume | 2.92M USD |
| Avg. Volume | 6.1M USD |
| Market Cap | 1.73B USD |
| Beta (5Y Monthly) | 2.33 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.78 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13.78 USD |
ABSI Valuation Measures
| Enterprise Value | 1.47B USD |
| Trailing P/E | N/A |
| Forward P/E | -16.400816 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 942.03564 |
| Price/Book (mrq) | 9.223125 |
| Enterprise Value/Revenue | 800.926 |
| Enterprise Value/EBITDA | -12.629 |
Trading Information
Absci Stock Price History
| Beta (5Y Monthly) | 2.33 |
| 52-Week Change | 298.49% |
| S&P500 52-Week Change | 20.84% |
| 52 Week High | 12.06 USD |
| 52 Week Low | 2.24 USD |
| 50-Day Moving Average | 7.23 USD |
| 200-Day Moving Average | 4.27 USD |
ABSI Share Statistics
| Avg. Volume (3 month) | 6.1M USD |
| Avg. Daily Volume (10-Days) | 6.36M USD |
| Shares Outstanding | 169.4M |
| Float | 148.81M |
| Short Ratio | 4.62 |
| % Held by Insiders | 12.04% |
| % Held by Institutions | 73.00% |
| Shares Short | 36.94M |
| Short % of Float | 26.61% |
| Short % of Shares Outstanding | 21.80% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -14346.97% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -37.33% |
| Return on Equity (ttm) | -63.88% |
Income Statement
| Revenue (ttm) | 1.84M USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | -81.79% |
| Gross Profit (ttm) | -81793000 USD |
| EBITDA | -116437000 USD |
| Net Income Avi to Common (ttm) | -118436000 USD |
| Diluted EPS (ttm) | -0.82 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 125.71M USD |
| Total Cash Per Share (mrq) | 0.81 USD |
| Total Debt (mrq) | 4.42M USD |
| Total Debt/Equity (mrq) | 2.57 USD |
| Current Ratio (mrq) | 6.589 |
| Book Value Per Share (mrq) | 1.107 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -97393000 USD |
| Levered Free Cash Flow (ttm) | -41475376 USD |
Profile of Absci
| Country | United States |
| State | WA |
| City | Vancouver |
| Address | 18105 SE Mill Plain Boulevard |
| ZIP | 98683 |
| Phone | 360 949 1041 |
| Website | https://www.absci.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 140 |
Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Q&A For Absci Stock
What is a current ABSI stock price?
Absci ABSI stock price today per share is 9.76 USD.
How to purchase Absci stock?
You can buy ABSI shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Absci?
The stock symbol or ticker of Absci is ABSI.
Which industry does the Absci company belong to?
The Absci industry is Biotechnology.
How many shares does Absci have in circulation?
The max supply of Absci shares is 169.4M.
What is Absci Price to Earnings Ratio (PE Ratio)?
Absci PE Ratio is now.
What was Absci earnings per share over the trailing 12 months (TTM)?
Absci EPS is -0.78 USD over the trailing 12 months.
Which sector does the Absci company belong to?
The Absci sector is Healthcare.
Absci ABSI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26269.23 USD — |
+0.62
|
6.33B USD — | 26041.13 USD — | 26316.81 USD — | — - | 6.33B USD — |
|
US Tech Global Select Market Com
NQGS
US
|
12896.68 USD — |
+0.63
|
— — | 12785.35 USD — | 12920.04 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6562.03 USD — |
+0.7
|
— — | 6454.97 USD — | 6563.4 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1251.97 USD — |
+0.86
|
— — | 1233.72 USD — | 1252.49 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}